Diabetes mellitus ☆: A hypercoagulable state

作者: Marcus E Carr

DOI: 10.1016/S1056-8727(00)00132-X

关键词: Von Willebrand factorClotting factorMedicineInternal medicineHemostasisPlateletDiabetes mellitusPlatelet factor 4HyperinsulinemiaCoagulationEndocrinology

摘要: Eighty percent of patients with diabetes mellitus die a thrombotic death. Seventy-five these deaths is due to cardiovascular complications, and the remainder cerebrovascular events peripheral vascular complications. Vascular endothelium, primary defense against thrombosis, abnormal in diabetes. Endothelial abnormalities undoubtedly play role enhanced activation platelets clotting factors seen Coagulation markers, such as prothrombin fragment 1+2 thrombin-anti-thrombin complexes, are elevated The plasma levels many including fibrinogen, factor VII, VIII, XI, XII, kallikrein, von Willebrand Conversely, level anticoagulant protein C (PC) decreased. fibrinolytic system, means removing clots, relatively inhibited clot structures that more resistant degradation an increase plasminogen activator inhibitor type 1 (PAI-1). Increased circulating platelet aggregates, increased aggregation response agonists, contractile force (PCF), presence higher release products, beta-thromboglobulin, 4, thromboxane B(2), demonstrate hyperactivity This constellation findings supports clinical observation hypercoagulable state. article briefly reviews published evidence for this conclusion putative roles played by hyperglycemia hyperinsulinemia its development.

参考文章(41)
Acang N, Jalil Fd, Hypercoagulation in diabetes mellitus. Southeast Asian Journal of Tropical Medicine and Public Health. pp. 263- 266 ,(1993)
Robert L. Jones, Charles M. Peterson, Reduced Fibrinogen Survival in Diabetes Mellitus Journal of Clinical Investigation. ,vol. 63, pp. 485- 493 ,(1979) , 10.1172/JCI109326
Doron Aronson, Elliot J Rayfield, James H Chesebro, Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction Annals of Internal Medicine. ,vol. 126, pp. 296- 306 ,(1997) , 10.7326/0003-4819-126-4-199702150-00006
T. Murakami, Y. Komiyama, H. Egawa, K. Murata, Elevation of Factor Xla—α1-Antitrypsin Complex Levels in NIDDM Patients With Diabetic Nephropathy Diabetes. ,vol. 42, pp. 233- 238 ,(1993) , 10.2337/DIAB.42.2.233
M. Small, J.T. Douglas, G.D.O. Lowe, A.C. MacCuish, C.D. Forbes, Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus. Haemostasis. ,vol. 16, pp. 417- 423 ,(1986) , 10.1159/000215318
Yolanda López, Maria José Paloma, José Rifón, Braulia Cuesta, José A. Páramo, Measurement of Prethrombotic Markers in the Assessment of Acquired Hypercoagulable States Thrombosis Research. ,vol. 93, pp. 71- 78 ,(1999) , 10.1016/S0049-3848(98)00165-0
ANDREW I. SCHAFER, The Hypercoagulable States Annals of Internal Medicine. ,vol. 102, pp. 814- 828 ,(1985) , 10.7326/0003-4819-102-6-814
Takashi Nagai, Change of Lipoprotein (a) and Coagulative or Fibrinolytic Parameters in Diabetic Patients with Nephropathy Journal of Atherosclerosis and Thrombosis. ,vol. 1, pp. 37- 40 ,(1994) , 10.5551/JAT1994.1.37
Michael Shechter, C.Noel Bairey Merz, Maura J Paul-Labrador, Sanjay Kaul, Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease Journal of the American College of Cardiology. ,vol. 35, pp. 300- 307 ,(2000) , 10.1016/S0735-1097(99)00545-8
Satoshi Fujii, Daisuke Goto, Tarikuz Zaman, Naoki Ishimori, Keiko Watano, Takeaki Kaneko, Hitoshi Okada, Mituyuki Makiguchi, Toshiaki Nakagawa, Akira Kitabatake, Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis. Journal of Atherosclerosis and Thrombosis. ,vol. 5, pp. 76- 81 ,(1998) , 10.5551/JAT1994.5.76